|
1
|
Böhmer FD and Friedrich K: Protein
tyrosine phosphatases as wardens of STAT signaling. JAK-STAT.
3:e280872014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Becerra-Díaz M, Valderrama-Carvajal H and
Terrazas LI: Signal transducers and activators of transcription
(STAT) family members in helminth infections. Int J Biol Sci.
7:1371–1381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calò V, Migliavacca M, Bazan V, Macaluso
M, Buscemi M, Gebbia N and Russo A: STAT proteins: From normal
control of cellular events to tumorigenesis. J Cell Physiol.
197:157–168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao B, Wang H, Lafdil F and Feng D: STAT
proteins - key regulators of anti-viral responses, inflammation,
and tumorigenesis in the liver. J Hepatol. 57:430–441. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sobti RC, Singh N, Hussain S, Suri V,
Bharadwaj M and Das BC: Deregulation of STAT-5 isoforms in the
development of HPV-mediated cervical carcinogenesis. J Recept
Signal Transduct Res. 30:178–188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan S, Li B, Bai ZZ, Wu JQ, Xie DW, Ma YC,
Ma XX, Zhao JH and Guo XJ: Clinical epidemiology of gastric cancer
in Hehuang valley of China: A 10-year epidemiological study of
gastric cancer. World J Gastroenterol. 20:10486–10494. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rahman AF, Korashy HM and Kassem MG:
Gefitinib. Profiles Drug Subst Excip Relat Methodol. 39:239–264.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blumenberg M: Differential transcriptional
effects of EGFR inhibitors. PLoS One. 9:e1024662014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baik M, Yu JH and Hennighausen L: Growth
hormone-STAT 5 regulation of growth, hepatocellular carcinoma, and
liver metabolism. Ann NY Acad Sci. 1229:29–37. 2011. View Article : Google Scholar
|
|
11
|
Bourgeais J, Gouilleux-Gruart V and
Gouilleux F: Oxidative metabolism in cancer: A STAT affair?
JAK-STAT. 2:e257642013. View Article : Google Scholar
|
|
12
|
Quintás-Cardama A and Verstovsek S:
Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and
resistance. Clin Cancer Res. 19:1933–1940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hennighausen L and Robinson GW:
Interpretation of cytokine signaling through the transcription
factors STAT 5A and STAT 5B. Genes Dev. 22:711–721. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mirtti T, Leiby BE, Abdulghani J, Aaltonen
E, Pavela M, Mamtani A, Alanen K, Egevad L, Granfors T, Josefsson
A, et al: Nuclear STAT 5a/b predicts early recurrence and prostate
cancer-specific death in patients treated by radical prostatectomy.
Hum Pathol. 44:310–319. 2013. View Article : Google Scholar :
|
|
15
|
Kim DY, Cha ST, Ahn DH, Kang HY, Kwon CI,
Ko KH, Hwang SG, Park PW, Rim KS and Hong SP: STAT3 expression in
gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol.
24:646–651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peck AR, Witkiewicz AK, Liu C, Klimowicz
AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH,
et al: Low levels of STAT 5a protein in breast cancer are
associated with tumor progression and unfavorable clinical
outcomes. Breast Cancer Res. 14:R1302012. View Article : Google Scholar
|
|
17
|
Kaymaz BT, Selvi N, Gündüz C, Aktan C,
Dalmızrak A, Saydam G and Kosova B: Repression of STAT3, STAT 5A,
and STAT 5B expressions in chronic myelogenous leukemia cell line
K-562 with unmodified or chemically modified siRNAs and induction
of apoptosis. Ann Hematol. 92:151–162. 2013. View Article : Google Scholar
|
|
18
|
Du W, Wang YC, Hong J, Su WY, Lin YW, Lu
R, Xiong H and Fang JY: STAT 5 isoforms regulate colorectal cancer
cell apoptosis via reduction of mitochondrial membrane potential
and generation of reactive oxygen species. J Cell Physiol.
227:2421–2429. 2012. View Article : Google Scholar
|
|
19
|
Riggins RB, Thomas KS, Ta HQ, Wen J, Davis
RJ, Schuh NR, Donelan SS, Owen KA, Gibson MA, Shupnik MA, et al:
Physical and functional interactions between Cas and c-Src induce
tamoxifen resistance of breast cancer cells through pathways
involving epidermal growth factor receptor and signal transducer
and activator of transcription 5b. Cancer Res. 66:7007–7015. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi M, Cooper JC and Yu CL: A
constitutively active Lck kinase promotes cell proliferation and
resistance to apoptosis through signal transducer and activator of
transcription 5b activation. Mol Cancer Res. 4:39–45. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ledgerwood EC and Morison IM: Targeting
the apoptosome for cancer therapy. Clin Cancer Res. 15:420–424.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCracken JM and Allen LA: Regulation of
human neutrophil apoptosis and lifespan in health and disease. J
Cell Death. 7:15–23. 2014.PubMed/NCBI
|
|
23
|
Pajak B, Gajkowska B and Orzechowski A:
Molecular basis of parthenolide-dependent proapoptotic activity in
cancer cells. Folia Histochem Cytobiol. 46:129–135. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Debierre-Grockiego F: Anti-apoptotic role
of STAT 5 in haematopoietic cells and in the pathogenesis of
malignancies. Apoptosis. 9:717–728. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hardwick JM and Soane L: Multiple
functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol.
5:a0087222013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin S, Yang C, Wang X, Xu C, Li S, Zhang B
and Ren H: Overexpression of Smac promotes Cisplatin-induced
apoptosis by activating caspase-3 and caspase-9 in lung cancer A549
cells. Cancer Biother Radiopharm. 28:177–182. 2013. View Article : Google Scholar
|
